The marine microalgae chrypthecodinium conhii (c. Cohnii) contains high levels of docosahexaenoic acid (DHA) and DHA synthase enzymes (DSE)

Ended Project Grant Awarded Last action

Award ID
NA23OAR0210333
Recipient
Awarding agency
Obligated
$1,300,000

Award facts

Completion date
Place of performance
Brunswick, ME 04011, USA

Award details come from USAspending.gov.

Description

Finfish have shown DE novo synthesis of DHA when FED a c. Cohnii product, konisap , developed by FPN LLC. Konisap is unique to the aqua-feed market as IT is produced under low temperature and inert gas to prevent lipid oxidation and avoid enzyme denaturation. This phase II will conduct atlantic salmon feeding trials using konisap aimed to quantify the activity of DSE. The quantification of DSE activity will provide accurate feeding methods to establish sufficient accumulation of DHA in adult fish. The ultimate goal of this research is to demonstrate konisap production potential and provide the parameters in which aquaculturists can use konisap to fortify the DHA contents of their product. Increases in DHA concentration in fish provides added value at market.

Transactions

Action Obligated Date
Amendment $0
Amendment $650,000
Original award $650,000

Quick answers

Who received award NA23OAR0210333?

NA23OAR0210333 was awarded to FPN LLC by National Oceanic and Atmospheric Administration (Department of Commerce) on August 1, 2023.

How much is award NA23OAR0210333 worth?

$1,300,000 has been obligated on NA23OAR0210333.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award